Pfizer has announced the approval of HYMPAVZI by the US Food and Drug Administration (FDA) for patients with haemophilia A ...

Hympavzi (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and ...

The FDA granted the approval of Hympavzi to Pfizer Inc.

Pfizer announced on Friday that the U.S. Food and Drug Administration has granted approval for its once-weekly injection ...

Pfizer’s Hympavzi receives US FDA approval to treat adults and adolescents with haemophilia A or B without inhibitors: New York Monday, October 14, 2024, 18:00 Hrs [IST] Pfizer ...

The once-weekly injectable joins one-shot haemophilia B gene therapy Beqvez (fidanacogene elaparvovec) in Pfizer’s portfolio, ...

TSMC is planning new factories in Europe focused on AI chips after starting construction on its first plant in Dresden, ...

Sanofi has announced negotiations with Clayton Dubilier & Rice (CD&R), regarding the potential sale of a 50% controlling ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

Anders Carlson, Matt Orzech welcome challenges from Greg Joseph, Peter Bowden ...

Leaders worried the former president could force Ukraine to cede land to Russia in exchange for a ceasefire if he wins the election ...

Elon Musk Unveils the Long-Awaited Robotaxi and Tesla's Autonomous Future ...